Antibodies Targeting the V1V2 Domain of gp120 Display Strong ADCC and Inhibitory Activities

被引:0
|
作者
Mayr, Luzia [1 ,2 ]
Decoville, Thomas [1 ]
Schmidt, Sylvie [1 ]
Laumond, Geraldine [1 ]
Ducloy, Camille [1 ,2 ]
Klingler, Jeromine [1 ,2 ]
Salome, Nathalie [1 ]
Zolla-Pazner, Susan [3 ]
Moog, Christiane [1 ,2 ]
机构
[1] Univ Strasbourg, FMTS, INSERM, U1109, Strasbourg, France
[2] Vaccine Res Inst, Paris, France
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
PD02.01
引用
收藏
页码:111 / 111
页数:1
相关论文
共 50 条
  • [21] HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens
    Shen, Xiaoying
    Laher, Fatima
    Moodie, Zoe
    McMillan, Arthur S.
    Spreng, Rachel L.
    Gilbert, Peter B.
    Huang, Ying
    Yates, Nicole L.
    Grunenberg, Nicole
    McElrath, M. Juliana
    Allen, Mary
    Pensiero, Michael
    Mehra, Vijay L.
    Van Der Meeren, Olivier
    Barnett, Susan W.
    Phogat, Sanjay
    Gray, Glenda E.
    Bekker, Linda-Gail
    Corey, Lawrence
    Tomaras, Georgia D.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [22] Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
    Mayr, Luzia M.
    Decoville, Thomas
    Schmidt, Sylvie
    Laumond, Geraldine
    Klingler, Jeromine
    Ducloy, Camille
    Bahram, Seiamak
    Zolla-Pazner, Susan
    Moog, Christiane
    SCIENTIFIC REPORTS, 2017, 7
  • [23] Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
    Luzia M. Mayr
    Thomas Decoville
    Sylvie Schmidt
    Géraldine Laumond
    Jéromine Klingler
    Camille Ducloy
    Seiamak Bahram
    Susan Zolla-Pazner
    Christiane Moog
    Scientific Reports, 7
  • [24] Potent neutralization of a macrophage-tropic HIV-1 isolate by antibodies against the V1/V2 domain of HIV-1 gp120
    Honnen, WJ
    Wu, ZW
    Kayman, SC
    Pinter, A
    VACCINES 96 - MOLECULAR APPROACHES TO THE CONTROL OF INFECTIOUS DISEASES, 1996, : 289 - 297
  • [25] A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies
    Doria-Rose, Nicole A.
    Georgiev, Ivelin
    O'Dell, Sijy
    Chuang, Gwo-Yu
    Staupe, Ryan P.
    McLellan, Jason S.
    Gorman, Jason
    Pancera, Marie
    Bonsignori, Mattia
    Haynes, Barton F.
    Burton, Dennis R.
    Koff, Wayne C.
    Kwong, Peter D.
    Mascola, John R.
    JOURNAL OF VIROLOGY, 2012, 86 (15) : 8319 - 8323
  • [26] Antibody Responses to Recombinant gp120, gp70 V1V2 Proteins and Cyclic V2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
    Karasavvas, N.
    Karnasuta, C.
    de Souza, M. S.
    Madnote, S.
    Inthawong, D.
    Savadsuk, H.
    Rittiroongrad, S.
    Chantakulkij, S.
    Nitayaphan, S.
    Pitisuttithum, P.
    Thongcharoen, P.
    Siriyanon, V.
    Andrews, C. A.
    O'Connell, R. J.
    Michael, N. L.
    Ngauy, V.
    Kim, J. H.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A50 - A50
  • [27] REPERTOIRE OF NEUTRALIZING HUMAN MONOCLONAL-ANTIBODIES SPECIFIC FOR THE V3 DOMAIN OF HIV-1 GP120
    GORNY, MK
    XU, JY
    KARWOWSKA, S
    BUCHBINDER, A
    ZOLLAPAZNER, S
    JOURNAL OF IMMUNOLOGY, 1993, 150 (02): : 635 - 643
  • [28] Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120
    Pinter, A
    Honnen, WJ
    Kayman, SC
    Trochev, O
    Wu, Z
    VACCINE, 1998, 16 (19) : 1803 - 1811
  • [29] MVA-expressed gp140 Boosts More Durable V1/V2 and gp120 Antibody Responses than gp120 Protein in Alum
    Shen, Xiaoying
    Basu, Rahul
    Kwa, Suefen
    Labranche, Celia
    Beaumont, David
    Ferrari, Guido
    Wyatt, Linda
    Moss, Bernard
    Montefiori, David
    Tomaras, Georgia
    Robinson, Harriet
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 59 - 59
  • [30] Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
    Jason S. McLellan
    Marie Pancera
    Chris Carrico
    Jason Gorman
    Jean-Philippe Julien
    Reza Khayat
    Robert Louder
    Robert Pejchal
    Mallika Sastry
    Kaifan Dai
    Sijy O’Dell
    Nikita Patel
    Syed Shahzad-ul-Hussan
    Yongping Yang
    Baoshan Zhang
    Tongqing Zhou
    Jiang Zhu
    Jeffrey C. Boyington
    Gwo-Yu Chuang
    Devan Diwanji
    Ivelin Georgiev
    Young Do Kwon
    Doyung Lee
    Mark K. Louder
    Stephanie Moquin
    Stephen D. Schmidt
    Zhi-Yong Yang
    Mattia Bonsignori
    John A. Crump
    Saidi H. Kapiga
    Noel E. Sam
    Barton F. Haynes
    Dennis R. Burton
    Wayne C. Koff
    Laura M. Walker
    Sanjay Phogat
    Richard Wyatt
    Jared Orwenyo
    Lai-Xi Wang
    James Arthos
    Carole A. Bewley
    John R. Mascola
    Gary J. Nabel
    William R. Schief
    Andrew B. Ward
    Ian A. Wilson
    Peter D. Kwong
    Nature, 2011, 480 : 336 - 343